| 0 |
HEADACHE |
10 |
| 1 |
INCORRECT DOSE ADMINISTERED |
10 |
| 2 |
WEIGHT INCREASED |
10 |
| 3 |
FATIGUE |
9 |
| 4 |
NAUSEA |
7 |
| 5 |
OFF LABEL USE |
6 |
| 6 |
VOMITING |
6 |
| 7 |
ASPARTATE AMINOTRANSFERASE INCREASED |
5 |
| 8 |
CONDITION AGGRAVATED |
5 |
| 9 |
ERYTHEMA |
5 |
| 10 |
ILLNESS |
5 |
| 11 |
PYREXIA |
5 |
| 12 |
SINUSITIS |
5 |
| 13 |
WEIGHT DECREASED |
5 |
| 14 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
| 15 |
COUGH |
4 |
| 16 |
NASOPHARYNGITIS |
4 |
| 17 |
PAIN IN EXTREMITY |
4 |
| 18 |
RASH |
4 |
| 19 |
URTICARIA |
4 |
| 20 |
ANAPHYLACTIC REACTION |
3 |
| 21 |
COVID-19 |
3 |
| 22 |
DIZZINESS |
3 |
| 23 |
DYSPNOEA |
3 |
| 24 |
HEART RATE INCREASED |
3 |
| 25 |
INFLUENZA |
3 |
| 26 |
MYALGIA |
3 |
| 27 |
PAIN |
3 |
| 28 |
POOR VENOUS ACCESS |
3 |
| 29 |
ABDOMINAL DISTENSION |
2 |
| 30 |
BALANCE DISORDER |
2 |
| 31 |
BODY TEMPERATURE INCREASED |
2 |
| 32 |
DIARRHOEA |
2 |
| 33 |
FALL |
2 |
| 34 |
FEELING HOT |
2 |
| 35 |
FLUSHING |
2 |
| 36 |
GAIT DISTURBANCE |
2 |
| 37 |
HEPATIC ENZYME INCREASED |
2 |
| 38 |
HYPERHIDROSIS |
2 |
| 39 |
HYPOTENSION |
2 |
| 40 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
| 41 |
INFECTION |
2 |
| 42 |
INFLAMMATION |
2 |
| 43 |
MALAISE |
2 |
| 44 |
MUSCLE TIGHTNESS |
2 |
| 45 |
NASAL CONGESTION |
2 |
| 46 |
NERVOUS SYSTEM DISORDER |
2 |
| 47 |
NO ADVERSE EVENT |
2 |
| 48 |
OXYGEN SATURATION DECREASED |
2 |
| 49 |
PNEUMONIA |
2 |
| 50 |
PRURITUS |
2 |
| 51 |
RESPIRATORY DISTRESS |
2 |
| 52 |
RHINORRHOEA |
2 |
| 53 |
SINUS CONGESTION |
2 |
| 54 |
SNEEZING |
2 |
| 55 |
TRANSAMINASES INCREASED |
2 |
| 56 |
ABDOMINAL DISCOMFORT |
1 |
| 57 |
ABDOMINAL PAIN |
1 |
| 58 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
| 59 |
ACUTE HEPATIC FAILURE |
1 |
| 60 |
ANGIOEDEMA |
1 |
| 61 |
AORTIC VALVE REPLACEMENT |
1 |
| 62 |
ARTHRALGIA |
1 |
| 63 |
ARTHROPOD BITE |
1 |
| 64 |
ASTHENIA |
1 |
| 65 |
AXILLARY MASS |
1 |
| 66 |
BILE ACIDS INCREASED |
1 |
| 67 |
BLOOD GLUCOSE INCREASED |
1 |
| 68 |
BLOOD PRESSURE INCREASED |
1 |
| 69 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
| 70 |
BONE PAIN |
1 |
| 71 |
BURSITIS |
1 |
| 72 |
CARDIAC OPERATION |
1 |
| 73 |
CATHETERISATION CARDIAC |
1 |
| 74 |
CHILLS |
1 |
| 75 |
CHOLESTASIS OF PREGNANCY |
1 |
| 76 |
CLUMSINESS |
1 |
| 77 |
CYANOSIS |
1 |
| 78 |
CYSTITIS |
1 |
| 79 |
DEEP VEIN THROMBOSIS |
1 |
| 80 |
DEHYDRATION |
1 |
| 81 |
DISORIENTATION |
1 |
| 82 |
DRUG INEFFECTIVE |
1 |
| 83 |
DRUG INTOLERANCE |
1 |
| 84 |
DRUG SPECIFIC ANTIBODY PRESENT |
1 |
| 85 |
EAR INFECTION |
1 |
| 86 |
EAR PAIN |
1 |
| 87 |
EXPOSURE TO SARS-COV-2 |
1 |
| 88 |
EXTRASYSTOLES |
1 |
| 89 |
EYE DISCHARGE |
1 |
| 90 |
FLATULENCE |
1 |
| 91 |
FOOT DEFORMITY |
1 |
| 92 |
FURUNCLE |
1 |
| 93 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
| 94 |
GASTROENTERITIS |
1 |
| 95 |
HEPATIC LESION |
1 |
| 96 |
HORDEOLUM |
1 |
| 97 |
HOSPITALISATION |
1 |
| 98 |
HYDROCHOLECYSTIS |
1 |
| 99 |
HYPERAEMIA |
1 |
| 100 |
HYPERBILIRUBINAEMIA |
1 |
| 101 |
HYPERTENSION |
1 |
| 102 |
HYPERTRANSAMINASAEMIA |
1 |
| 103 |
ILL-DEFINED DISORDER |
1 |
| 104 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
| 105 |
INFUSION RELATED REACTION |
1 |
| 106 |
INFUSION SITE ERYTHEMA |
1 |
| 107 |
INFUSION SITE REACTION |
1 |
| 108 |
INFUSION SITE SWELLING |
1 |
| 109 |
INFUSION SITE URTICARIA |
1 |
| 110 |
INTENTIONAL DOSE OMISSION |
1 |
| 111 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
| 112 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
| 113 |
INTERSTITIAL LUNG DISEASE |
1 |
| 114 |
IRON DEFICIENCY |
1 |
| 115 |
LIGAMENT SPRAIN |
1 |
| 116 |
LUNG INFILTRATION |
1 |
| 117 |
LYMPHADENITIS |
1 |
| 118 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
| 119 |
METABOLIC ACIDOSIS |
1 |
| 120 |
MIGRAINE |
1 |
| 121 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
| 122 |
MUSCLE CONTRACTURE |
1 |
| 123 |
NASAL DISORDER |
1 |
| 124 |
NECK PAIN |
1 |
| 125 |
NEUTROPENIA |
1 |
| 126 |
NIEMANN-PICK DISEASE |
1 |
| 127 |
NIGHT SWEATS |
1 |
| 128 |
NOSOCOMIAL INFECTION |
1 |
| 129 |
OCCULT BLOOD POSITIVE |
1 |
| 130 |
OCULAR HYPERAEMIA |
1 |
| 131 |
ORAL PAIN |
1 |
| 132 |
OTITIS EXTERNA |
1 |
| 133 |
OVARIAN CANCER STAGE IV |
1 |
| 134 |
OVERDOSE |
1 |
| 135 |
PARAESTHESIA |
1 |
| 136 |
PNEUMONIA ASPIRATION |
1 |
| 137 |
POLLAKIURIA |
1 |
| 138 |
POST PROCEDURAL COMPLICATION |
1 |
| 139 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
| 140 |
PRODUCT PRESCRIBING ISSUE |
1 |
| 141 |
PROTHROMBIN TIME PROLONGED |
1 |
| 142 |
RALES |
1 |
| 143 |
RESPIRATORY ARREST |
1 |
| 144 |
RESPIRATORY DISORDER |
1 |
| 145 |
RESPIRATORY FAILURE |
1 |
| 146 |
RHINOVIRUS INFECTION |
1 |
| 147 |
ROAD TRAFFIC ACCIDENT |
1 |
| 148 |
SCARLET FEVER |
1 |
| 149 |
SCOLIOSIS |
1 |
| 150 |
SCREAMING |
1 |
| 151 |
SEIZURE |
1 |
| 152 |
SENSORY DISTURBANCE |
1 |
| 153 |
SPEECH DISORDER DEVELOPMENTAL |
1 |
| 154 |
SPINAL PAIN |
1 |
| 155 |
STRIDOR |
1 |
| 156 |
SWELLING OF EYELID |
1 |
| 157 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
| 158 |
TACHYCARDIA |
1 |
| 159 |
TACHYPNOEA |
1 |
| 160 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
| 161 |
THERAPEUTIC RESPONSE DECREASED |
1 |
| 162 |
TOOTH ABSCESS |
1 |
| 163 |
TOOTHACHE |
1 |
| 164 |
TREATMENT NONCOMPLIANCE |
1 |
| 165 |
URINARY TRACT INFECTION |
1 |
| 166 |
UROSEPSIS |
1 |
| 167 |
UTERINE POLYP |
1 |
| 168 |
VEIN RUPTURE |
1 |
| 169 |
VIRAL INFECTION |
1 |
| 170 |
WEIGHT FLUCTUATION |
1 |
| 171 |
WHEEZING |
1 |